SHILPA MEDICARE LTD.

NSE : SHILPAMEDBSE : 530549ISIN CODE : INE790G01031Industry : Pharmaceuticals & DrugsHouse : Private
BSE534.558.55 (+1.63 %)
PREV CLOSE ( ) 526.00
OPEN PRICE ( ) 523.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 63871
TODAY'S LOW / HIGH ( )515.00 541.00
52 WK LOW / HIGH ( )228.25 558
NSE534.5510.1 (+1.93 %)
PREV CLOSE( ) 524.45
OPEN PRICE ( ) 523.75
BID PRICE (QTY) 534.55 (1450)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 514687
TODAY'S LOW / HIGH( ) 515.00 541.00
52 WK LOW / HIGH ( )228.5 557.7
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax-382.801022.651950.521880.521356.78
Adjustment1481.471093.4257.62416.72284.54
Changes In working Capital1486.79-719.91-1062.86-631.50187.15
Cash Flow after changes in Working Capital2585.461396.16945.281665.751828.47
Cash Flow from Operating Activities2261.721051.33469.281243.781467.80
Cash Flow from Investing Activities-2784.84-2854.98-4042.76-2895.18-1961.64
Cash Flow from Financing Activities457.98828.584363.741755.02100.60
Net Cash Inflow / Outflow-65.14-975.07790.26103.63-393.25
Opening Cash & Cash Equivalents253.391228.46443.14341.30738.28
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANA-1.79-1.42
Closing Cash & Cash Equivalent188.25253.391233.40443.14343.61

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.